Literature DB >> 8344482

Tumor suppressor genes studied by cell hybridization and chromosome transfer.

M J Anderson1, E J Stanbridge.   

Abstract

Although the cloning of tumor suppressor genes has proved to be an arduous task, often involving several years of labor intensive cloning strategies, a greater understanding of neoplastic progression will be made once the function and role of these genes have been sorted out. To fully appreciate the state at which this field of research currently is, however, one must understand that the road to tumor suppression was paved by both somatic cell hybridization and chromosome transfer studies. Although regarded by many as laboratory artifact, somatic cell hybridization has provided strong circumstantial evidence, if not formal proof, for the existence of tumor suppressor genes. In further reducing the complexity associated with whole genome transfer, single chromosome transfer was subsequently developed as a refinement to this technique so that one could unequivocally correlate suppression with a particular chromosome. We have learned from these studies that single chromosomes harbor the genetic information necessary to reverse the malignant phenotype associated with cancer cells. Furthermore, multiple tumor suppressor loci are now known to exist, with one to several different loci associated with a given tumor type. In this review, we present evidence for tumor suppressor genes and discuss the early studies that led to their discovery.

Entities:  

Mesh:

Year:  1993        PMID: 8344482     DOI: 10.1096/fasebj.7.10.8344482

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  12 in total

Review 1.  Adult stem cell plasticity: introduction to the first issue of stem cell reviews.

Authors:  Stewart Sell
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

2.  Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice.

Authors:  Y Yang; M Kost-Alimova; S Ingvarsson; Q Qianhui; H Kiss; A Szeles; I Kholodnyuk; A Cuthbert; G Klein; S Imreh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

Review 3.  The manipulation of chromosomes by mankind: the uses of microcell-mediated chromosome transfer.

Authors:  Karen J Meaburn; Christopher N Parris; Joanna M Bridger
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

Review 4.  Tumor suppressor genes in molecular medicine.

Authors:  F Hoppe-Seyler; K Butz
Journal:  Clin Investig       Date:  1994-08

Review 5.  Antisense oncogene and tumor suppressor gene therapy of cancer.

Authors:  W W Zhang
Journal:  J Mol Med (Berl)       Date:  1996-04       Impact factor: 4.599

6.  Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3.

Authors:  Maria Kost-Alimova; Hajnalka Kiss; Ludmila Fedorova; Ying Yang; Jan P Dumanski; George Klein; Stefan Imreh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-08       Impact factor: 11.205

7.  Positioning of human chromosomes in murine cell hybrids according to synteny.

Authors:  Karen J Meaburn; Robert F Newbold; Joanna M Bridger
Journal:  Chromosoma       Date:  2008-07-24       Impact factor: 4.316

8.  Biological behaviors and proteomics analysis of hybrid cell line EAhy926 and its parent cell line A549.

Authors:  Ze Jun Lu; Ya Qiong Ren; Guo Ping Wang; Qi Song; Mei Li; Sa Sa Jiang; Tao Ning; Yong Song Guan; Jin Liang Yang; Feng Luo
Journal:  J Exp Clin Cancer Res       Date:  2009-02-13

9.  Replication of somatic micronuclei in bovine enucleated oocytes.

Authors:  Natalia Canel; Romina Bevacqua; María Inés Hiriart; Daniel Salamone
Journal:  Cell Div       Date:  2012-11-22       Impact factor: 5.130

Review 10.  Cell fusions in mammals.

Authors:  Lars-Inge Larsson; Bolette Bjerregaard; Jan Fredrik Talts
Journal:  Histochem Cell Biol       Date:  2008-03-20       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.